SPRING VALLEY ACQUISIT-RIGHT (SVIIR) Stock Fundamental Analysis

NASDAQ:SVIIR • KYG837521320

0.7657 USD
+0.02 (+2.08%)
Last: Oct 20, 2025, 08:17 PM
Overview Stock Chart Technical Analysis News
Fundamental Rating

1

Taking everything into account, SVIIR scores 1 out of 10 in our fundamental rating. SVIIR was compared to 0 industry peers in the Unkown industry. The financial health of SVIIR is average, but there are quite some concerns on its profitability. SVIIR is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • In the past year SVIIR was profitable.
  • In the past year SVIIR has reported a negative cash flow from operations.
SVIIR Yearly Net Income VS EBIT VS OCF VS FCFSVIIR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 2M 4M 6M 8M 10M

1.2 Ratios

Industry RankSector Rank
ROA 9.12%
ROE 9.99%
ROIC N/A
ROA(3y)10.36%
ROA(5y)N/A
ROE(3y)11.02%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SVIIR Yearly ROA, ROE, ROICSVIIR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 10 20

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for SVIIR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SVIIR Yearly Profit, Operating, Gross MarginsSVIIR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. Health

2.1 Basic Checks

  • Compared to 1 year ago, SVIIR has less shares outstanding
  • There is no outstanding debt for SVIIR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
SVIIR Yearly Shares OutstandingSVIIR Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 10M 20M 30M
SVIIR Yearly Total Debt VS Total AssetsSVIIR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

  • SVIIR has an Altman-Z score of 1.73. This is a bad value and indicates that SVIIR is not financially healthy and even has some risk of bankruptcy.
  • SVIIR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 1.73
ROIC/WACCN/A
WACCN/A
SVIIR Yearly LT Debt VS Equity VS FCFSVIIR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 50M 100M 150M 200M

2.3 Liquidity

  • SVIIR has a Current Ratio of 0.13. This is a bad value and indicates that SVIIR is not financially healthy enough and could expect problems in meeting its short term obligations.
  • A Quick Ratio of 0.13 indicates that SVIIR may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.13
Quick Ratio 0.13
SVIIR Yearly Current Assets VS Current LiabilitesSVIIR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 500K 1M 1.5M 2M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. Growth

3.1 Past

  • The earnings per share for SVIIR have decreased strongly by -86.85% in the last year.
EPS 1Y (TTM)-86.85%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-113.97%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocksShow best growing peers

1

4. Valuation

4.1 Price/Earnings Ratio

  • SVIIR is valuated reasonably with a Price/Earnings ratio of 10.94.
  • SVIIR is valuated cheaply when we compare the Price/Earnings ratio to 26.99, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 10.94
Fwd PE N/A
SVIIR Price Earnings VS Forward Price EarningsSVIIR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SVIIR Per share dataSVIIR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5 2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • SVIIR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

SPRING VALLEY ACQUISIT-RIGHT

NASDAQ:SVIIR (10/20/2025, 8:17:46 PM)

0.7657

+0.02 (+2.08%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)08-13
Earnings (Next)11-12
Inst Owners34.21%
Inst Owner Change-15.51%
Ins Owners1.21%
Ins Owner ChangeN/A
Market Cap7.57M
Revenue(TTM)N/A
Net Income(TTM)2.40M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 10.94
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.31
P/tB 0.31
EV/EBITDA N/A
EPS(TTM)0.07
EY9.14%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.07
FCFYN/A
OCF(TTM)-0.07
OCFYN/A
SpS0
BVpS2.43
TBVpS2.43
PEG (NY)N/A
PEG (5Y)N/A
Graham Number1.96
Profitability
Industry RankSector Rank
ROA 9.12%
ROE 9.99%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)10.36%
ROA(5y)N/A
ROE(3y)11.02%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.13
Quick Ratio 0.13
Altman-Z 1.73
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-86.85%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-113.97%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y20.9%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y45.38%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y45.38%
OCF growth 3YN/A
OCF growth 5YN/A

SPRING VALLEY ACQUISIT-RIGHT / SVIIR FAQ

Can you provide the ChartMill fundamental rating for SPRING VALLEY ACQUISIT-RIGHT?

ChartMill assigns a fundamental rating of 1 / 10 to SVIIR.


Can you provide the valuation status for SPRING VALLEY ACQUISIT-RIGHT?

ChartMill assigns a valuation rating of 1 / 10 to SPRING VALLEY ACQUISIT-RIGHT (SVIIR). This can be considered as Overvalued.


What is the profitability of SVIIR stock?

SPRING VALLEY ACQUISIT-RIGHT (SVIIR) has a profitability rating of 0 / 10.


What is the valuation of SPRING VALLEY ACQUISIT-RIGHT based on its PE and PB ratios?

The Price/Earnings (PE) ratio for SPRING VALLEY ACQUISIT-RIGHT (SVIIR) is 10.94 and the Price/Book (PB) ratio is 0.31.